DLB
Dolby Laboratories, Inc.
NYSEUSDEQUITY
Industrials
DELAYED
Neutral
+2/100
Last price
58.34
▼ 0.12 (0.21%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
58.28
Prev close
58.46
Day high
58.70
Day low
57.53
Volume
691.02K
Market cap
$5.47B
P/E (TTM)
24.83
52W range
48.26 – 71.24
Day trading desk
Gap from prior close
-0.31%
Prior close 58.46
VWAP
58.04
+0.51% from price
Relative volume
0.75×
Normal
Session range
2.05%
57.53 – 58.71
Position in range
69%
Mid range
ATR (14D)
1.41
2.42% of price
Prior day high
59.68
PDH
Prior day low
58.34
PDL
Bid / ask spread
—
Quote not published
Session volume
699.53K
Avg 928.70K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-0.71%
-2.6%
1M
-6.37%
-7.8%
3M
+16.42%
+13.0%
6M
-5.01%
-20.0%
YTD
-9.14%
-23.1%
1Y
-19.71%
-35.4%
3Y
-27.70%
-109.6%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on DLB open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+777.99K
Net buying
Buy transactions
10
854.33K shares
Sell transactions
13
76.35K shares
Net transactions
+23
Buys less sells
Sell : buy shares
0.1 : 1
Mixed
Insider-held shares
1.75M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Oct 1, 26 | COULING JOHN D Officer |
SELL | 7.67K | $450.69K | Direct |
| Oct 1, 26 | COULING JOHN D Officer |
CONVERSION | 7.67K | $348.85K | Direct |
| Sep 15, 26 | WHITTEN MARC R Chief Executive Officer |
STOCK | 160.26K | $0 | Direct |
| Sep 15, 26 | COULING JOHN D Officer |
STOCK | 48.08K | $0 | Direct |
| Sep 1, 26 | COULING JOHN D Officer |
SELL | 7.67K | $468.03K | Direct |
| Sep 1, 26 | COULING JOHN D Officer |
CONVERSION | 7.67K | $348.85K | Direct |
| Aug 28, 26 | DOLBY DAGMAR Beneficial Owner of more than 10% of a Class of Security |
— | 300.00K | — | Indirect |
| Aug 28, 26 | DOLBY DAGMAR Beneficial Owner of more than 10% of a Class of Security |
STOCK | 300.00K | $0 | Indirect |
| Aug 25, 26 | NICHOLSON RYAN Officer |
SELL | 1.18K | $77.22K | Direct |
| Aug 14, 26 | REVANKAR SHRIRAM Officer |
SELL | 3.00K | $188.13K | Direct |
| Aug 10, 26 | NICHOLSON RYAN Officer |
SELL | 1.35K | $83.63K | Direct |
| Aug 4, 26 | NICHOLSON RYAN Officer |
SELL | 357 | $21.64K | Direct |
| Aug 3, 26 | COULING JOHN D Officer |
SELL | 7.67K | $460.00K | Direct |
| Aug 3, 26 | COULING JOHN D Officer |
CONVERSION | 7.67K | $348.85K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
COULING JOHN D |
Officer | 166.80K | Sale |
DOLBY DAVID |
Director and Beneficial Owner of more than 10% of a Class of Security | 92.72K | Stock Award(Grant) |
GOTCHER PETER C |
Director | 44.64K | Stock Award(Grant) |
PARK ROBERT J. |
Chief Financial Officer | 81.49K | Sale |
REVANKAR SHRIRAM |
Officer | 73.27K | Sale |
SEGARS SIMON |
Director | 47.15K | Stock Award(Grant) |
SHERMAN MARK ANDREW |
General Counsel | 70.56K | Sale |
TEVANIAN AVADISJR |
Director | 66.58K | Stock Award(Grant) |
WHITTEN MARC R |
Chief Executive Officer | 160.26K | Stock Award(Grant) |
YEAMAN KEVIN J |
Chief Executive Officer | — | Sale |
Fundamentals
Market cap$5.47B
Enterprise value$4.85B
Revenue (TTM)$1.35B
Gross profit$1.19B
EBITDA$354.67M
Net income$226.18M
EPS (TTM)$2.35
Free cash flow$331.85M
Total cash$670.05M
Total debt$47.45M
Book value / share$27.59
Shares outstanding59.42M
Float58.76M
Short % of float12.51%
Dividend yield2.47%
Beta (5Y)0.78
Valuation & profitability ratios
Trailing P/E24.83
Forward P/E12.74
PEG ratio1.29
Price / sales—
Price / book2.11
EV / revenue3.58
EV / EBITDA13.68
Gross margin87.61%
Operating margin12.55%
Profit margin16.70%
Return on equity8.76%
Return on assets5.15%
Debt / equity1.83
Current ratio3.19
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $1.35B | $1.27B | $1.30B | $1.25B | +5.9% |
| Operating revenue | $1.35B | $1.27B | $1.30B | $1.25B | +5.9% |
| Cost of revenue | $160.13M | $140.50M | $152.57M | $141.36M | +14.0% |
| Gross profit | $1.19B | $1.13B | $1.15B | $1.11B | +4.9% |
| Research & development | $261.79M | $263.66M | $271.52M | $261.17M | -0.7% |
| Selling, general & admin | $647.24M | $604.85M | $612.84M | $634.03M | +7.0% |
| Total operating expense | $909.03M | $868.51M | $884.36M | $895.21M | +4.7% |
| Operating income | $279.97M | $264.71M | $262.81M | $217.23M | +5.8% |
| Net interest income | $15.38M | $34.08M | $28.09M | $6.17M | -54.9% |
| Pre-tax income | $303.49M | $312.48M | $250.05M | $215.28M | -2.9% |
| Tax provision | $46.99M | $48.16M | $48.41M | $31.38M | -2.4% |
| Net income | $255.02M | $261.82M | $200.66M | $184.09M | -2.6% |
| Net income to common | $255.02M | $261.82M | $200.66M | $184.09M | -2.6% |
| Basic EPS | 2.66 | 2.74 | 2.10 | 1.84 | -2.9% |
| Diluted EPS | 2.62 | 2.69 | 2.05 | 1.81 | -2.6% |
| EBIT | $279.97M | $264.71M | $262.81M | $217.23M | +5.8% |
| EBITDA | $378.56M | $352.04M | $358.33M | $320.84M | +7.5% |
| Basic shares | 95.87M | 95.54M | 95.77M | 99.99M | +0.3% |
| Diluted shares | 97.48M | 97.33M | 97.73M | 101.98M | +0.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $701.89M | $482.05M | $745.36M | $620.13M | +45.6% |
| Cash & short-term investments | $702.60M | $482.05M | $884.51M | $809.34M | +45.8% |
| Accounts receivable | $331.10M | $315.46M | $262.25M | $243.59M | +5.0% |
| Inventory | $30.42M | $33.73M | $35.62M | $23.55M | -9.8% |
| Total current assets | $1.39B | $1.19B | $1.49B | $1.31B | +16.2% |
| Property, plant & equipment | $503.81M | $518.15M | $521.78M | $560.01M | -2.8% |
| Goodwill & intangibles | $926.96M | $967.72M | $575.84M | $477.41M | -4.2% |
| Total assets | $3.23B | $3.11B | $2.98B | $2.69B | +3.8% |
| Total current liabilities | $437.79M | $417.84M | $422.23M | $277.52M | +4.8% |
| Total debt | $38.88M | $46.99M | $50.65M | $50.94M | -17.3% |
| Total liabilities | $595.81M | $623.03M | $607.58M | $438.53M | -4.4% |
| Retained earnings | $2.63B | $2.50B | $2.39B | $2.30B | +5.6% |
| Shareholder equity | $2.62B | $2.48B | $2.36B | $2.25B | +5.9% |
| Working capital | $950.47M | $776.58M | $1.07B | $1.03B | +22.4% |
| Net tangible assets | $1.70B | $1.51B | $1.78B | $1.77B | +12.3% |
| Shares issued | 95.46M | 95.39M | 95.76M | 95.88M | +0.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $256.49M | $264.32M | $201.64M | $183.90M | -3.0% |
| Depreciation & amortisation | $98.60M | $87.33M | $95.51M | $103.61M | +12.9% |
| Stock-based compensation | $128.51M | $119.83M | $118.49M | $114.92M | +7.3% |
| Change in working capital | -$17.01M | -$118.71M | -$47.08M | -$56.25M | +85.7% |
| Operating cash flow | $472.20M | $327.25M | $367.08M | $318.58M | +44.3% |
| Capital expenditure | -$41.94M | -$30.01M | -$30.34M | -$59.46M | -39.8% |
| Investing cash flow | -$10.59M | -$286.29M | $54.21M | -$295.94M | +96.3% |
| Share buybacks | -$162.23M | -$199.08M | -$180.42M | -$566.90M | +18.5% |
| Dividends paid | -$126.60M | -$114.58M | -$103.41M | -$100.07M | -10.5% |
| Financing cash flow | -$247.24M | -$287.81M | -$236.81M | -$610.56M | +14.1% |
| Free cash flow | $430.26M | $297.25M | $336.74M | $259.12M | +44.7% |
| End cash position | $793.36M | $577.75M | $817.97M | $628.37M | +37.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $305.00M | $395.63M | $346.71M | $307.02M | $315.55M | -22.9% |
| Operating revenue | $305.00M | $395.63M | $346.71M | $307.02M | $315.55M | -22.9% |
| Cost of revenue | $40.32M | $44.73M | $43.21M | $39.52M | $44.00M | -9.9% |
| Gross profit | $264.68M | $350.90M | $303.50M | $267.50M | $271.54M | -24.6% |
| Research & development | $65.75M | $63.65M | $69.08M | $67.47M | $65.98M | +3.3% |
| Selling, general & admin | $160.66M | $172.12M | $161.79M | $164.24M | $158.47M | -6.7% |
| Total operating expense | $226.41M | $235.77M | $230.87M | $231.70M | $224.45M | -4.0% |
| Operating income | $38.27M | $115.13M | $72.63M | $35.80M | $47.09M | -66.8% |
| Net interest income | $3.45M | $5.02M | $4.12M | $5.06M | $4.11M | -31.3% |
| Pre-tax income | $43.80M | $119.70M | $71.60M | $41.67M | $55.52M | -63.4% |
| Tax provision | $14.59M | $24.25M | $17.92M | -$7.99M | $8.97M | -39.8% |
| Net income | $28.60M | — | — | — | — | — |
| Net income to common | $28.60M | $94.92M | $53.33M | $49.33M | $46.07M | -69.9% |
| Basic EPS | 0.30 | 1.00 | 0.56 | 0.52 | 0.48 | -70.0% |
| Diluted EPS | 0.30 | 0.99 | 0.55 | 0.51 | 0.48 | -69.7% |
| EBIT | $38.27M | $115.13M | $72.63M | $35.80M | $47.09M | -66.8% |
| EBITDA | $63.34M | $141.98M | $99.44M | $60.38M | $71.49M | -55.4% |
| Basic shares | 94.24M | 95.22M | 95.47M | 95.63M | 95.90M | -1.0% |
| Diluted shares | 94.52M | 95.52M | 96.52M | 96.85M | 96.90M | -1.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $669.39M | $594.28M | $643.85M | $701.89M | $698.57M | +12.6% |
| Cash & short-term investments | $670.05M | $594.74M | $644.58M | $702.60M | $699.33M | +12.7% |
| Accounts receivable | $285.15M | $391.29M | $373.09M | $331.10M | $297.61M | -27.1% |
| Inventory | $30.77M | $31.93M | $31.26M | $30.42M | $32.41M | -3.6% |
| Total current assets | $1.33B | $1.41B | $1.41B | $1.39B | $1.34B | -6.3% |
| Property, plant & equipment | $501.52M | $506.60M | $502.29M | $503.81M | $511.43M | -1.0% |
| Goodwill & intangibles | $910.78M | $919.38M | $894.32M | $926.96M | $936.97M | -0.9% |
| Total assets | $3.16B | $3.25B | $3.19B | $3.23B | $3.20B | -2.9% |
| Total current liabilities | $416.33M | $474.61M | $443.51M | $437.79M | $388.79M | -12.3% |
| Total debt | $47.45M | $49.69M | $40.64M | $38.88M | $39.11M | -4.5% |
| Total liabilities | $563.89M | $622.36M | $589.25M | $595.81M | $581.75M | -9.4% |
| Retained earnings | $2.60B | $2.63B | $2.60B | $2.63B | $2.62B | -1.2% |
| Shareholder equity | $2.58B | $2.62B | $2.59B | $2.62B | $2.60B | -1.3% |
| Working capital | $909.71M | $940.10M | $964.55M | $950.47M | $949.33M | -3.2% |
| Net tangible assets | $1.67B | $1.70B | $1.70B | $1.70B | $1.67B | -1.5% |
| Shares issued | 93.65M | 94.59M | 95.53M | 95.46M | 95.39M | -1.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $29.21M | $95.45M | $53.68M | $49.65M | $46.54M | -69.4% |
| Depreciation & amortisation | $25.07M | $26.85M | $26.81M | $24.57M | $24.40M | -6.6% |
| Stock-based compensation | $30.96M | $30.71M | $37.21M | $31.05M | $30.73M | +0.8% |
| Change in working capital | $90.55M | -$72.09M | -$56.55M | -$12.17M | -$32.37M | +225.6% |
| Operating cash flow | $167.46M | $92.51M | $54.80M | $122.83M | $67.69M | +81.0% |
| Capital expenditure | -$19.79M | -$46.09M | -$5.38M | -$21.84M | -$6.43M | +57.1% |
| Investing cash flow | -$9.79M | -$46.09M | $1.25M | -$21.91M | -$6.43M | +78.8% |
| Share buybacks | -$65.89M | -$66.03M | -$101.20M | -$37.08M | -$41.20M | +0.2% |
| Dividends paid | -$33.98M | -$34.34M | -$34.34M | -$31.59M | -$31.63M | +1.0% |
| Financing cash flow | -$91.02M | -$99.88M | -$121.83M | -$64.06M | -$60.74M | +8.9% |
| Free cash flow | $147.67M | $46.42M | $49.42M | $100.99M | $61.26M | +218.1% |
| End cash position | $738.89M | $673.80M | $727.57M | $793.36M | $756.56M | +9.7% |
Options analytics
Put / call volume
0.40
Call-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
55.00
-5.7% from spot
ATM implied vol
6.3%
Nearest strike to spot
Skew (10% OTM)
0.0%
Calls bid over puts
Call volume
15
Contracts, this expiry
Put volume
6
Contracts, this expiry
Heaviest call OI
60.00
0 contracts
Heaviest put OI
55.00
0 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.67 | 0.69 | +3.0% |
| Mar 2026 | 1.34 | 1.37 | +2.5% |
| Dec 2025 | 0.99 | 1.06 | +6.7% |
| Sep 2025 | 0.71 | 0.99 | +40.4% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 1.20 | 4 | $372.76M | +21.4% |
| Next quarter | 1.12 | 4 | $359.33M | +3.6% |
| Current year | 4.32 | 4 | $1.43B | +5.7% |
| Next year | 4.58 | 4 | $1.47B | +2.9% |
Analyst targets & ownership
Mean target$79.00
High target$90.00
Low target$62.00
Implied upside35.41%
Analyst count3
ConsensusNONE
Strong buy / Buy1 / 2
Hold1
Sell / Strong sell0 / 0
Held by insiders1.87%
Held by institutions106.71%
Institutions holding554
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
58.51
-0.30% from price
SMA 20
59.11
-1.28% from price
SMA 50
60.57
-3.66% from price
SMA 100
56.46
+3.33% from price
SMA 200
59.60
-2.09% from price
EMA 12
58.77
-0.74% from price
EMA 26
59.29
-1.60% from price
EMA 50
59.04
-1.18% from price
RSI (14)
44.5
Neutral
MACD (12,26,9)
-0.51
Hist 0.01
ATR (14)
1.41
2.42% of price
Realised vol 30D
25.4%
Annualised
Bollinger upper
62.75
20, 2σ
Bollinger lower
55.46
20, 2σ
50 / 200 cross
Golden
60.57 vs 59.60
Trend bias
Below 200
-2.09%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.59
Less volatile than market
Correlation to SPY
0.26
Largely independent
Realised vol 30D
25.4%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-31.7%
Peak to trough
Max drawdown 5Y
-49.6%
Peak to trough
ATR 14
1.41
2.42% of price
Beta (reported)
0.78
5Y monthly, from filing
Short interest
Shares short
5.53M
Prior 5.89M
Change vs prior
-6.1%
Shorts covering
% of float
12.51%
Elevated
% of shares out
5.90%
Against total outstanding
Days to cover
5.8
Crowded exit
Float
58.76M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 28, 26 | Rosenblatt | MAINTAINED | Buy | Buy |
| Jul 31, 26 | Rosenblatt | MAINTAINED | Buy | Buy |
| Jun 15, 26 | Barrington Research | MAINTAINED | Outperform | Outperform |
| Jun 11, 26 | Rosenblatt | MAINTAINED | Buy | Buy |
| Apr 27, 26 | Barrington Research | MAINTAINED | Outperform | Outperform |
| Jan 30, 26 | Barrington Research | MAINTAINED | Outperform | Outperform |
| Jan 30, 26 | Rosenblatt | MAINTAINED | Buy | Buy |
| Jan 26, 26 | Barrington Research | MAINTAINED | Outperform | Outperform |
| Jan 22, 26 | Rosenblatt | MAINTAINED | Buy | Buy |
| Nov 19, 25 | Rosenblatt | MAINTAINED | Buy | Buy |
| Nov 19, 25 | Barrington Research | MAINTAINED | Outperform | Outperform |
| Sep 12, 25 | Barrington Research | MAINTAINED | Outperform | Outperform |
Dividends & splits
Forward rate$1.44 / yr
Forward yield2.47%
5-year avg yield1.49%
Payout ratio60.00%
Ex-dividend dateAug 11, 2026
Next pay dateAug 19, 2026
Last split—
Split date—
SEC filings
Offering Registrations
S-8 · 2026-09-11
Corporate Changes & Voting Matters
8-K · 2026-08-27
Corporate Changes & Voting Matters
8-K · 2026-07-30
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
SD · 2026-05-29
Corporate Changes & Voting Matters
8-K · 2026-04-30
Corporate Changes & Voting Matters
8-K · 2026-02-06
Periodic Financial Reports
10-Q · 2026-01-29
Annual Report to Shareholders
ARS · 2025-12-16
Headlines
Dolby Laboratories' Atmos Spatial Audio to Be Used on Apple TV's Formula 1 Broadcasts
MT Newswires · 18h ago
Formula 1® on Apple TV to Debut in Dolby Atmos, Alongside Dolby Vision, Delivering a More Immersive Race Experience
PR Newswire · 19h ago
1 Cash-Heavy Stock with Exciting Potential and 2 That Underwhelm
StockStory · 2d ago
1 Cash-Producing Stock Worth Your Attention and 2 We Turn Down
StockStory · 3d ago
Your Meta AI Glasses Are Getting a Dolby Upgrade
Benzinga · 13d ago
Dolby Laboratories (DLB) Could Be 27% Below Fair Value After Meta Expansion
Simply Wall St. · 13d ago
Is Meta (META) Quietly Rewriting Its Hardware Strategy Through Muse-Powered Ray-Ban AI Glasses?
Simply Wall St. · 13d ago
How Meta’s Expanded Dolby Atmos and Vision Integration At Dolby Laboratories (DLB) Has Changed Its Investment Story
Simply Wall St. · 14d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.